Related Experiment Video
Updated: May 7, 2026

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines
Published on: November 9, 2020
Protector turns predator: Autophagic death via selective degradation of KRAS
Latika Kohli1, Niroop Kaza, Steven L Carroll
1Department of Pathology; University of Alabama at Birmingham; Birmingham, AL USA; Department of Cell Biology; University of Alabama at Birmingham; Birmingham, AL USA.
Abstract:
Therapy-induced autophagy is recognized as a critical determinant of treatment outcome in cancer patients, primarily as a factor underlying drug resistance. However, recent investigations point toward a context-dependent, death-inducing role for autophagy, the mechanism of which remains largely unknown. Our recent study provides evidence that autophagy can directly mediate cell killing in multiple tumor cell types by facilitating degradation of KRAS/K-Ras, a key survival protein. These findings have broad implications for strategies employing autophagy modulation to target tumor cells.
Insights
Autophagy, a cellular process, can kill cancer cells by degrading the KRAS survival protein. This discovery offers new strategies for cancer therapy by targeting this pathway.
Area of Science:
- Cancer Biology
- Cellular Mechanisms
- Drug Resistance
Background:
- Therapy-induced autophagy is a key factor in cancer treatment outcomes, often linked to drug resistance.
- The precise role of autophagy in cancer cell death is context-dependent and not fully understood.
Purpose of the Study:
- To investigate the mechanism by which autophagy can directly mediate cancer cell killing.
- To explore the role of KRAS degradation in autophagy-induced cell death.
Main Methods:
- Utilized multiple tumor cell types to study autophagy-mediated cell death.
- Investigated the degradation of KRAS/K-Ras protein as a potential mechanism.
Main Results:
- Demonstrated that autophagy can directly cause cell death in various tumor cells.
- Showed that this cell killing is facilitated by the degradation of the KRAS survival protein.
Conclusions:
- Autophagy can act as a direct cell-killing mechanism in cancer.
- Targeting autophagy-mediated KRAS degradation presents a novel therapeutic strategy for cancer treatment.
More Related Videos
09:18Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death
Published on: December 27, 2016
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
Related Concept Videos
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Cellular Injury V: Apoptosis and Autophagy
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...